IOBT

IOBT

IO Biotech Inc. Common Stock

$1.500+0.000 (0.000%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.500

Kõrge

$1.500

Madal

$1.500

Maht

0.38M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

GlobeNewswire

IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that

Vaata rohkem
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
GlobeNewswire

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025Data presented at recent

Vaata rohkem
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights